{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T04:16:32Z","timestamp":1784175392075,"version":"3.55.0"},"reference-count":69,"publisher":"Informa UK Limited","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Future Med. Chem."],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.4155\/fmc.09.123","type":"journal-article","created":{"date-parts":[[2009,12,8]],"date-time":"2009-12-08T16:12:54Z","timestamp":1260288774000},"page":"1723-1736","source":"Crossref","is-referenced-by-count":27,"title":["Drug Repositioning Using\n            <i>In Silico<\/i>\n            Compound Profiling"],"prefix":"10.1080","volume":"1","author":[{"given":"Elodie","family":"Dubus","sequence":"first","affiliation":[{"name":"Aureus Pharma, 174 Quai de Jemmapes, 75010Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail","family":"Ijjaali","sequence":"additional","affiliation":[{"name":"Aureus Pharma, 174 Quai de Jemmapes, 75010Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Barberan","sequence":"additional","affiliation":[{"name":"Aureus Pharma, 174 Quai de Jemmapes, 75010Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Petitet","sequence":"additional","affiliation":[{"name":"Aureus Pharma, 174 Quai de Jemmapes, 75010Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2009,12,8]]},"reference":[{"key":"e_1_3_3_3_1_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1980.tb00342.x"},{"key":"e_1_3_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1359-6446(04)03307-0"},{"key":"e_1_3_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1468"},{"key":"e_1_3_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2005.06.183"},{"key":"e_1_3_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200411-1587OC"},{"key":"e_1_3_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2005.06.040"},{"key":"e_1_3_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.107.162511"},{"key":"e_1_3_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.06-7526com"},{"key":"e_1_3_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2030"},{"key":"e_1_3_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.5.4.933"},{"key":"e_1_3_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1089324"},{"key":"e_1_3_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio806"},{"key":"e_1_3_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0802982105"},{"key":"e_1_3_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707305"},{"key":"e_1_3_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707306"},{"key":"e_1_3_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1228"},{"key":"e_1_3_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1021\/ci600300k"},{"key":"e_1_3_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1338"},{"key":"e_1_3_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1021\/ci8000259"},{"key":"e_1_3_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm701021b"},{"key":"e_1_3_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0609752104"},{"key":"e_1_3_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm701143p"},{"key":"e_1_3_3_3_23_1","unstructured":"Grau D SerbedzijaG. Innovative strategies for drug repurposing. Drug Discovery & Development. May 2005."},{"key":"e_1_3_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1284"},{"key":"e_1_3_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(98)00088-4"},{"key":"e_1_3_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002508-200006001-00013"},{"key":"e_1_3_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4892(01)00040-6"},{"issue":"12","key":"e_1_3_3_3_28_1","first-page":"S24","article-title":"The role of anticholinergics in chronic obstructive pulmonary disease.","volume":"117","author":"Barnes PJ","year":"2004","unstructured":"Barnes PJ . The role of anticholinergics in chronic obstructive pulmonary disease.Am. J. Med.117(Suppl. 12A), S24\u2013S32 (2004).","journal-title":"Am. J. Med."},{"key":"e_1_3_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(01)00395-8"},{"issue":"3","key":"e_1_3_3_3_30_1","first-page":"479","article-title":"The mammalian target of the rapamycin (mTOR) kinase pathway: its role in tumourigenesis and targeted antitumour therapy.","volume":"10","author":"Janus A","year":"2005","unstructured":"Janus A , RobakT, SmolewskiP. The mammalian target of the rapamycin (mTOR) kinase pathway: its role in tumourigenesis and targeted antitumour therapy.Cell. Mol. Biol. Lett.10(3), 479\u2013498 (2005).","journal-title":"Cell. Mol. Biol. Lett."},{"key":"e_1_3_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602902"},{"key":"e_1_3_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.106.115329"},{"key":"e_1_3_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0b013e3282f370af"},{"key":"e_1_3_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/17.6.973"},{"key":"e_1_3_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.regpep.2009.03.011"},{"key":"e_1_3_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.2174\/092986707782360141"},{"key":"e_1_3_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(01)01301-2"},{"key":"e_1_3_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.5.11.2397"},{"key":"e_1_3_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1517\/14728222.12.10.1257"},{"key":"e_1_3_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.physiol.65.092101.142528"},{"key":"e_1_3_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.5551\/jat.14.133"},{"key":"e_1_3_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.jbchem.a003164"},{"key":"e_1_3_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1080\/714037693"},{"key":"e_1_3_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-007-9056-9"},{"key":"e_1_3_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.2174\/138620707782507313"},{"key":"e_1_3_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.2174\/092986708785132843"},{"key":"e_1_3_3_3_47_1","doi-asserted-by":"crossref","unstructured":"Mason JS MigeonJ DupuisP Otto-BucA. Use of broad biological profiling as relevant descriptor to describe and differentiate compounds: structure-in vitro (pharmacology-ADME)-in vivo (safety) relationships. In: Methods and Principles in Medicinal Chemistry: Antitargets (Volume 38). Vaz RJ Klabunde T (Eds). Wiley-VCH Verlag GmbH & Co. Weinheim Germany 23\u201352 (2008).","DOI":"10.1002\/9783527621460.ch2"},{"key":"e_1_3_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm020155c"},{"key":"e_1_3_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1021\/ci060003g"},{"key":"e_1_3_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707307"},{"key":"e_1_3_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.2174\/138620708785739952"},{"key":"e_1_3_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm800504q"},{"key":"e_1_3_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm060902w"},{"key":"e_1_3_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1359-6446(05)03632-9"},{"key":"e_1_3_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2.3.381"},{"key":"e_1_3_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.2174\/092986707782794087"},{"key":"e_1_3_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1158140"},{"key":"e_1_3_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.200700026"},{"key":"e_1_3_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1021\/ci800344p"},{"key":"e_1_3_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm801546k"},{"key":"e_1_3_3_4_2_1","unstructured":"Using in silico compound profiling to boost and optimize drug discovery www.aureus-pharma.com"},{"key":"e_1_3_3_4_3_1","unstructured":"ChemAxon chemistry software www.chemaxon.com"},{"key":"e_1_3_3_4_4_1","unstructured":"Talete consulting and software development www.talete.mi.it"},{"key":"e_1_3_3_4_5_1","unstructured":"Accelrys software www.accelrys.com"},{"key":"e_1_3_3_4_6_1","unstructured":"Daylight chemical information systems www.daylight.com"},{"key":"e_1_3_3_4_7_1","unstructured":"Tripos scientific solutions www.tripos.com"},{"key":"e_1_3_3_4_8_1","unstructured":"PharmaPendium drug information database www.pharmapendium.com"},{"key":"e_1_3_3_4_9_1","unstructured":"GeneGo pathway analysis www.genego.com\/metabase.php"},{"key":"e_1_3_3_5_2_1","unstructured":"Kosan Biosciences Inc: US0270616 (2006)."}],"container-title":["Future Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.4155\/fmc.09.123","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T19:50:33Z","timestamp":1716493833000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.4155\/fmc.09.123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":69,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["10.4155\/fmc.09.123"],"URL":"https:\/\/doi.org\/10.4155\/fmc.09.123","relation":{},"ISSN":["1756-8919","1756-8927"],"issn-type":[{"value":"1756-8919","type":"print"},{"value":"1756-8927","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}